期刊文献+
共找到5篇文章
< 1 >
每页显示 20 50 100
Assessing the Effectiveness of a Cervical Cancer Screening Program in a Hospital-based Study 被引量:11
1
作者 YANG Yi LANG Jing He +5 位作者 WANG You Fang CHENG Xue Mei CAI Yu Pin LI Hui ZHU Bao Li ZHANG Rui Fen 《Biomedical and Environmental Sciences》 SCIE CAS CSCD 2015年第1期80-84,共5页
This study compared HPV testing and liquid-based cytology (LCT) as performance indicators for cervical cancer screening in a hospital-based study. A total of 61,193 outpatients were screened initially by LCT. Sample... This study compared HPV testing and liquid-based cytology (LCT) as performance indicators for cervical cancer screening in a hospital-based study. A total of 61,193 outpatients were screened initially by LCT. Samples with screening results showing atypical squamous cells of undetermined significance (ASC-US) or worse were referred for colposcopy, and some samples were tested for high-risk HPV types with the Hybrid Capture II system (HC II). Data on LCT (n=61,193) and HC II (n=1056) results were analysed. Overall test positivity for LCT was 2.53% using an ASC-US threshold, 3.11% using a low-grade squamous intraepithelial lesion (LSIL) threshold, and 0.67% using a high-grade squamous intraepithelial lesion (HSIL) threshold. A total of 1839 women (84% of the 3893 patients with abnormal cytology) underwent colposcopy-directed biopsy. HPV was positive in 80.3% of women with cervical intraepithelial neoplasia 1 (CIN1), 88.3% of those with CIN2, 79.2% of women with CIN3 and 50% (2 of 4) of women with invasive cancer. There was a significant increase in the detection of CIN2 or worse with adjunct HPV testing of women with ASC-US and LSIL However, there were detection of CIN2+ cases no differences in the with adjunct HPV testing of women with HSlI.. The results indicate that HPV testing for HSlL triage should not be recommended in cervical cancer screening. 展开更多
关键词 HPV HSIL Assessing the Effectiveness of a Cervical Cancer screening Program in a Hospital-based Study
下载PDF
External validation of the Prostate Cancer Prevention Trial and the European Randomized Study of Screening for Prostate Cancer risk calculators in a Chinese cohort 被引量:10
2
作者 Yao Zhu Jin-You Wang +7 位作者 Yi-Jun Shen Bo Dai Chun-Guang Ma Wen-Jun Xiao Guo-Wen Lin Xu-Dong Yao Shi-Lin Zhang Ding-Wei Ye 《Asian Journal of Andrology》 SCIE CAS CSCD 2012年第5期738-744,共7页
Several prediction models have been developed to estimate the outcomes of prostate biopsies. Most of these tools were designed for use with Western populations and have not been validated across different ethnic group... Several prediction models have been developed to estimate the outcomes of prostate biopsies. Most of these tools were designed for use with Western populations and have not been validated across different ethnic groups. Therefore, we evaluated the predictive value of the Prostate Cancer Prevention Trial (PCPT) and the European Randomized Study of Screening for Prostate Cancer (ERSPC) risk calculators in a Chinese cohort. Clinicopathological information was obtained from 495 Chinese men who had undergone extended prostate biopsies between January 2009 and March 2011. The estimated probabilities of prostate cancer and high-grade disease (Gleason 〉6) were calculated using the PCPT and ERSPC risk calculators. Overall measures, discrimination, calibration and clinical usefulness were assessed for the model evaluation. Of these patients, 28.7% were diagnosed with prostate cancer and 19.4% had high-grade disease. Compared to the PCPT model and the prostate-specific antigen (PSA) threshold of 4 ng m1-1, the ERSPC risk calculator exhibited better discriminative ability for predicting positive biopsies and high-grade disease (the area under the curve was 0.831 and 0.852, respectively, P〈O.01 for both). Decision curve analysis also suggested the favourable clinical utility of the ERSPC calculator in the validation dataset. Both prediction models demonstrated miscalibration: the risk of prostate cancer and high-grade disease was overestimated by approximately 20% for a wide range of predicted probabilities. In conclusion, the ERSPC risk calculator outperformed both the PCPT model and the PSA threshold of 4 ng ml- z in predicting prostate cancer and high-grade disease in Chinese patients. However, the prediction tools derived from Western men significantly overestimated the probability of prostate cancer and high-grade disease compared to the outcomes of biopsies in a Chinese cohort. 展开更多
关键词 European Randomized Study of screening for Prostate Cancer (ERSPC) predictive value of tests prostate cancer prostate-specific antigen (PSA) Prostate Cancer Prevention Trial (PCPT)
下载PDF
Theoretical Study of Screening Dependence of Aluminium Doped MgB_2
3
作者 Gargee Sharma Smita Sharma 《Chinese Physics Letters》 SCIE CAS CSCD 2018年第3期79-83,共5页
The screening dependence of superconducting state parameters (λ, μ*, Tc, α and NoV) of six alloys of aluminium doped MgB2 systems are studied in the BCS-Eliashberg-MeMillan framework by employing five forms of ... The screening dependence of superconducting state parameters (λ, μ*, Tc, α and NoV) of six alloys of aluminium doped MgB2 systems are studied in the BCS-Eliashberg-MeMillan framework by employing five forms of dielectric screening function, viz. random phase approximation (RPA), Harrison, Geldart and Vosko (GV), Hubbard and Overhauser in conjunction with Ashcroft's potential. It is observed that electron-phonon coupling strength and Coulomb pseudopotential μ* are quite sensitive to the form of dielectric screening, whereas transition temperature Tc, isotope effect exponent α and effective interaction strength NoV show weak dependence on the form of dielectric screening function. It is found that the RPA form of dielectric screening function yields the best results for transition temperature Tc for all alloys of the Mg-Al-B system. The results obtained using GV screening are much higher than the experimental results. This shows that all the four dielectric screenings used here almost describe superconductivity in all the alloys of the Mg-Al-B system, but the GV screening is not suitable for such an alloy system. 展开更多
关键词 Theoretical Study of screening Dependence of Aluminium Doped MgB2 Al
下载PDF
Study on the screening result of anti-HCV in the blood donors
4
《中国输血杂志》 CAS CSCD 2001年第S1期338-,共1页
关键词 HCV Study on the screening result of anti-HCV in the blood donors
下载PDF
Comparative Study on 4 EIA Kits for Screening Antibody to Hepatitis C Virus in Pooled Sera
5
作者 LIU PEI SHI ZHI-XU +3 位作者 ZHANG YAN-CHAO AND ZHANG XIN-YING (Deportment of Public Health, twrtment of Infectious Disease,Xuzhou Medical College Xuzhou Red Cross BloodService, Xuzhou, Jiangsu, China) 《Biomedical and Environmental Sciences》 SCIE CAS CSCD 1998年第1期75-80,共6页
Four enzyme immunoassay (EIA) test kits, 1 Canadian product and 3 Chinese products,were used in the comparative study. Each pool consisted of 5 sera, and the 5 single sera were tested as controls. The tests were carri... Four enzyme immunoassay (EIA) test kits, 1 Canadian product and 3 Chinese products,were used in the comparative study. Each pool consisted of 5 sera, and the 5 single sera were tested as controls. The tests were carried out according to the instructions, keeping the same dilution of each serum in single and pool samples. It was found that with the Canadian kit,the positive and negative results of opled sera had no difference from that of the controls (P>0. 10). In the case of Chinese Yali and Kehua kits, the positive results of pooled sera showed no difference from the controls (P >0. 10), but the optical density (OD) of negative opls were increased (P < 0. 01 ), though quite distant from the cut-off values. In the case of Changzheng kit, the OD of opitive opls were significantly lower than those of the controls (P < 0. 05 ), and weak positive samples missed the detection. However this problem could be overcome by blocking the microwells beforehand. Our experiment demonstrate that not all EIA test kits are suitable for screening opls for antithey to hepatitis C virus, and that it is important to assess the sensitivity of the EIA kit to be used for this purpose. 展开更多
关键词 EIA Comparative Study on 4 EIA Kits for screening Antibody to Hepatitis C Virus in Pooled Sera
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部